You are here

Pfizer, BioNTech to co-develop potential coronavirus vaccine

[NEW YORK] US drugmaker Pfizer Inc has signed a deal with Germany's BioNTech SE to co-develop a potential vaccine for the coronavirus using BioNTech's mRNA-based drug development platform, the companies said on Tuesday.

The drugmakers will start the collaboration immediately and have...

BT is now on Telegram!

For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes